Back to Trades
Flanagan W. Michael
InsiderCIK 0001841990
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 7
- Buy transactions
- 0
- Sell transactions
- 4
- Companies
- 2
- Active
- 2025–2026
Flanagan W. Michael has filed 7 SEC reports (2025–2026), spread across 2 companies, totaling $10.0M in disclosed volume. Weighing $0 bought versus $1.4M sold, the history is heavily weighted toward selling. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
7 loaded
| Mar 2 | RNA Atrium Therapeutics, Inc. | Flanagan W. Michael | Insider | Award | $295.0K |
| Feb 27 | RNAM Avidity Biosciences, Inc. | Flanagan W. Michael | Insider | Disposed | $6.7M |
| Feb 26 | RNA Atrium Therapeutics, Inc. | Flanagan W. Michael | Insider | Other | $0 |
| Jan 23 | RNA Avidity Biosciences, Inc. | Flanagan W. Michael | Chief Scientific Officer | Sell | $473.4K |
| Jan 9 | RNA Avidity Biosciences, Inc. | Flanagan W. Michael | Chief Scientific Officer | Sell | $171.4K |
| Dec 19 | RNA Avidity Biosciences, Inc. | Flanagan W. Michael | Chief Scientific Officer | Grant | $984.3K |
| Sep 12 | RNA Avidity Biosciences, Inc. | Flanagan W. Michael | Chief Scientific Officer | Sell | $778.7K |
7 filings